Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
If approved, your prescription will be filled and shipped 4
The pace feels patient and controlled, which is the point
Liu X, Sun L, Zhang Y, et al
doi: 10.1136/bmj.c869 Summary Keywords obesity, GLP-1, GLP-1 receptor analog, exenatide, pediatrics, glycemic control, GLP-1 receptor agonist, treatment Citation Stenlid R, Cerenius SY, Wen Q, Aydin BK, Manell H, Chowdhury A, Kristinsson H, Ciba I, Gjessing ES, Mrwald K, Gomahr J, Heu V, Weghuber D, Forslund A and Bergsten P (2023) Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
US$ 24.34
US$ 27.19
US$ 23.38
US$ 29.47
US$ 26.66
US$ 25.15
US$ 29.90
